Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction

Authors

  • Luis A. López-Flores Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
  • Gloria Pérez-Rubio Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
  • Ramcés Falfán-Valencia Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas

DOI:

https://doi.org/10.17179/excli2016-847

Keywords:

CYP2A6, ethnic differences, genetic polymorphism, tobacco consumption, nicotine metabolism, nicotine addiction

Abstract

Tobacco consumption has become a major public health issue, which has motivated studies to identify and understand the biological processes involved in the smoking behavior for prevention and smoking cessation treatments. CYP2A6 has been identified as the main gene that codifies the enzyme that metabolizes nicotine. Many alleles have been identified after the discovery of CYP2A6, suggesting a wide interethnic variability and a diverse smoking behavior of the allele carrying individuals. The main purpose of this review is to update and highlight the effects of the CYP2A6 gene variability related to tobacco consumption reported from diverse human populations. The review further aims to consider CYP2A6 in future studies as a possible genetic marker for the prevention and treatment of nicotine addiction. Therefore, we analyzed several population studies and their importance at addressing and characterizing a population using specific parameters. Our efforts may contribute to a personalized system for detecting, preventing and treating populations at a higher risk of smoking to avoid diseases related to tobacco consumption.

Published

2017-03-06

How to Cite

López-Flores, L. A., Pérez-Rubio, G., & Falfán-Valencia, R. (2017). Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction. EXCLI Journal, 16, 174–196. https://doi.org/10.17179/excli2016-847

Issue

Section

Review articles